Daclizumab (Zenapax) is a humanized, monoclonal antibody that blocks CD25 (alpha-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab (Zenapax) reversibly binds to CD25and prevents the interaction of IL-2 with the IL-2R-HA.
Purity:
>99.0%
CAS Number:
[152923-56-3]
* VAT and and shipping costs not included. Errors and price changes excepted